Evidence map›Paper›PMID 37647107›Full record

ArticleBrain : a journal of neurology2024

Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation.

Stephen Keddie, Duncan Smyth, Ryan Y S Keh, Luuk Wieske, Milou Michael, Filip Eftimov, Roberto Bellanti, Simon Rinaldi, Axel Petzold, Michael P Lunn

Open access · hybridAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Peripherin, A New Promising Biomarker in Neurological Disorders.The European journal of neuroscience · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Stephen KeddieDepartment of Neuromuscular Diseases, Barts Health NHS Trust, London E1 1BB, UK.ORCID 0000-0002-2102-6053
Duncan SmythDepartment of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
Ryan Y S KehDepartment of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.ORCID 0000-0003-0799-2703
Luuk WieskeDepartment of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-2522-4081
Milou MichaelDepartment of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Filip EftimovDepartment of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Roberto BellantiNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Simon RinaldiNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Axel PetzoldDepartment of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-0344-9749
Michael P LunnDepartment of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.ORCID 0000-0003-3174-6027
Amsterdam Neuroscience · NLNational Hospital for Neurology and Neurosurgery · GBUniversity of Oxford · GBBarts Health NHS Trust · GB

Funding

Medical Research Council MR/X003922/1Medical Research Council MR/Y001826/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Guillain-Barre SyndromeAxonsBiomarkersHumansIntermediate FilamentsPeripherinsBiomarkersPeripherins

Identifiers

PMID37647107
PMCPMC10766229
OpenAlexW4386272511

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.